No Data
No Data
No Data
No Data
No Data
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
MARIETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced that it will report its operating and financial results for the first
GlobeNewswireApr 16 08:00 ET
MiMedx Group, Inc.'s (NASDAQ:MDXG) Prospects Need A Boost To Lift Shares
MiMedx Group, Inc.'s (NASDAQ:MDXG) price-to-sales (or "P/S") ratio of 3x might make it look like a strong buy right now compared to the Biotechs industry in the United States, where around half of the
Simply Wall StApr 12 09:38 ET
MiMedx Group (MDXG) Receives a Buy From Northland Securities
TipRanksMar 28 08:55 ET
Analysts Conflicted on These Healthcare Names: Cellectar Biosciences (CLRB), MiMedx Group (MDXG) and Marinus (MRNS)
TipRanksMar 28 07:50 ET
Merck, Cintas Rise; GameStop, MiMedx Fall, Wednesday, 3/27/2024
BarchartMar 27 16:27 ET
MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit
MiMedx Group said federal regulators are sticking to their position that its Axiofill product doesn't meet regulatory requirements for a certain classification sought by the company.
WSJMar 27 08:37 ET
No Data
No Data